We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-8.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.07B
AUM Growth
-$732M
Cap. Flow
-$324M
Cap. Flow %
-7.96%
Top 10 Hldgs %
18.03%
Holding
679
New
46
Increased
261
Reduced
260
Closed
64

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$31.9M
2
MCK icon
McKesson
MCK
+$27.5M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
SBUX icon
Starbucks
SBUX
+$27M
5
NVDA icon
NVIDIA
NVDA
+$21M

Sector Composition

Rank Sector Weight
1 Healthcare 28.72%
2 Financials 13.85%
3 Technology 10.05%
4 Consumer Discretionary 8.55%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DISCK
251
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3.3M 0.08%
135,690
+98,955
+269% +$2.75M
AGIO icon
252
Agios Pharmaceuticals
AGIO
$2.16B
$3.29M 0.08%
46,600
-1,400
-3% -$137K
BHC icon
253
Bausch Health
BHC
$1.65B
$3.25M 0.08%
18,243
-7,726
-30% -$1.8M
TFCFA
254
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$3.24M 0.08%
120,181
-4,670
-4% -$140K
F icon
255
Ford
F
$57.3B
$3.23M 0.08%
238,183
-53,556
-18% -$765K
CHRW icon
256
C.H. Robinson
CHRW
$22B
$3.23M 0.08%
47,632
+20,972
+79% +$1.41M
SBAC icon
257
SBA Communications
SBAC
$18.4B
$3.21M 0.08%
30,680
-3,901
-11% -$455K
HIG icon
258
Hartford Financial Services
HIG
$38.5B
$3.21M 0.08%
70,169
+40,736
+138% +$1.88M
UAL icon
259
United Airlines
UAL
$38.4B
$3.18M 0.08%
+59,865
New +$3.38M
RAI
260
DELISTED
Reynolds American Inc
RAI
$3.17M 0.08%
71,701
+9,815
+16% +$407K
HUM icon
261
Humana
HUM
$46.7B
$3.16M 0.08%
17,665
-793
-4% -$147K
DVAX
262
DELISTED
Dynavax Technologies
DVAX
$3.16M 0.08%
128,800
+76,800
+148% +$2.17M
MO icon
263
Altria Group
MO
$122B
$3.14M 0.08%
57,696
-51,324
-47% -$2.75M
ACAD icon
264
Acadia Pharmaceuticals
ACAD
$4.25B
$3.08M 0.08%
93,200
-48,800
-34% -$2.03M
EXC icon
265
Exelon
EXC
$48.6B
$3.06M 0.08%
144,302
-277,982
-66% -$6.25M
ROST icon
266
Ross Stores
ROST
$76.6B
$3.05M 0.08%
63,009
-169,156
-73% -$8.64M
BDX icon
267
Becton Dickinson
BDX
$43.1B
$3.01M 0.07%
23,223
+1,287
+6% +$180K
HST icon
268
Host Hotels & Resorts
HST
$16.8B
$3M 0.07%
189,973
-22,099
-10% -$414K
CA
269
DELISTED
CA, Inc.
CA
$3M 0.07%
110,005
+102,806
+1,428% +$2.94M
EQT icon
270
EQT Corp
EQT
$33.2B
$3M 0.07%
84,958
-7,722
-8% -$315K
ISEE
271
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.98M 0.07%
73,500
-11,500
-14% -$609K
TECH icon
272
Bio-Techne
TECH
$11.2B
$2.97M 0.07%
128,440
-47,560
-27% -$1.19M
PNW icon
273
Pinnacle West Capital
PNW
$12.9B
$2.96M 0.07%
46,172
-7,618
-14% -$466K
A icon
274
Agilent Technologies
A
$39.1B
$2.95M 0.07%
85,856
-291,733
-77% -$11M
CTAS icon
275
Cintas
CTAS
$82.4B
$2.93M 0.07%
136,748
-403,960
-75% -$8.67M

Similar funds

Candriam SCA's Q3 2015 Portfolio in Review

As of Q3 2015, Candriam SCA held 679 positions worth $4.07B, down 15% from $4.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $324M in Q3 2015, closing 64 positions and reducing 260 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Masco worth $14.9M.

  • Candriam SCA's largest Q3 2015 buy was Masco: 593,671 shares worth $14.9M.
  • Candriam SCA added most to Nike in Q3 2015, an estimated $31.9M increase.
  • Candriam SCA's biggest Q3 2015 reduction was iShares US Real Estate ETF, cutting an estimated $31.3M.
  • Candriam SCA fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $109M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.07B portfolio in Q3 2015.
  • Candriam SCA opened 46 new positions and closed 64 in Q3 2015.
  • Candriam SCA's portfolio value fell 15% quarter-over-quarter to $4.07B.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.